Strategic Wealth Advisors Group, LLC Mei Pharma, Inc. Transaction History

Strategic Wealth Advisors Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$0.54 - $2.74 $40,932 - $207,692	-75,800 Closed	0 $0
Q4 2021 Feb 16, 2022	SELL	$2.33 - $3.37 $209,001 - $302,289	-89,700 Reduced 54.2%	75,800 $208,000
Q3 2021 Nov 17, 2021	BUY	$2.52 - $2.99 $21,420 - $25,415	8,500 Added 5.41%	165,500 $457,000
Q2 2021 Aug 10, 2021	BUY	$2.6 - $3.65 $7,020 - $9,855	2,700 Added 1.75%	157,000 $447,000
Q1 2021 May 07, 2021	BUY	$2.73 - $4.5 $35,490 - $58,500	13,000 Added 9.2%	154,300 $529,000
Q4 2020 Feb 12, 2021	BUY	$2.6 - $3.32 $7,670 - $9,794	2,950 Added 2.13%	141,300 $373,000
Q3 2020 Nov 30, 2020	BUY	$2.46 - $4.27 $76,875 - $133,437	31,250 Added 29.18%	138,350 $432,000
Q2 2020 Aug 03, 2020	BUY	$1.45 - $4.3 $155,295 - $460,530	107,100 New	107,100 $453,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $385M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Strategic Wealth Advisors Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Strategic Wealth Advisors Group, LLC with notifications on news.